Modified ultrafiltration reduces postoperative blood loss and transfusions in adult cardiac surgery: a meta-analysis of randomized controlled trials.

OBJECTIVES Cardiopulmonary bypass in cardiac surgery has been associated with several deleterious effects including haemodilution and systemic inflammation. Modified ultrafiltration (MUF) has been well established in paediatric cardiac surgery in counteracting postperfusion syndrome. However, MUF is less commonly used in adult cardiac surgery. In this meta-analysis, we compared clinical outcomes in adult patients who underwent cardiopulmonary bypass with and without MUF. METHODS Electronic searches were performed using Pubmed, Ovid Medline, EMBASE and the Cochrane Library until April 2020. Selection criteria were randomized studies of adult cardiac surgery patients comparing MUF versus no MUF. Primary outcomes were postoperative mortality, haematocrit, blood transfusion, chest tube drainage, duration of intensive care unit (ICU) stay and duration of mechanical ventilation. RESULTS Thirteen randomized controlled trials were included, comprising 626 patients in the MUF group, and 610 patients in the control (no-MUF) group. There was a significantly improved postoperative haematocrit [mean difference 2.70, 95% confidence interval (CI) 0.68-4.73, P = 0.009], lower chest tube drainage (mean difference -105 ml, 95% CI -202 to -7 ml, P = 0.032), lower postoperative blood transfusion rate (mean difference -0.73 units, 95% CI -0.98 to -0.47 units, P < 0.0001) and shorter duration of ICU stay (mean difference -0.13 days, 95% CI -0.27 to -0.00 days, P = 0.048) in the MUF group. There was no difference in ventilation time (mean difference -0.47 h, 95% CI -2.05 to 1.12 h, P = 0.56) or mortality rates (odds ratio 0.62, 95% CI 0.28-1.33, P = 0.22). There were no reported complications associated with MUF. CONCLUSIONS MUF is a safe and feasible option in adult cardiac patients, with significant benefits including improved postoperative haematocrit, as well as reduced postoperative chest tube bleeding, transfusion requirements and duration of ICU stay.

[1]  A. Tabaei,et al.  Modified Ultrafiltration in Coronary Artery Bypass Grafting: A Randomized, Double-Blinded, Controlled Clinical Trial , 2018, Iranian Red Crescent Medical Journal.

[2]  A. Stammers,et al.  The effect of ultrafiltration on end-cardiopulmonary bypass hematocrit during cardiac surgery , 2018, Perfusion.

[3]  M. Gaudino,et al.  Acute respiratory distress syndrome after cardiac surgery. , 2016, Journal of thoracic disease.

[4]  M. Hall,et al.  Cardiopulmonary Bypass-Induced Inflammatory Response: Pathophysiology and Treatment , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[5]  J. Namchaisiri,et al.  The effects of modified ultrafiltration on clinical outcomes of adult and pediatric cardiac surgery , 2017 .

[6]  A. Vezzani,et al.  The Evolution of Cardiovascular Surgery in Elderly Patient: A Review of Current Options and Outcomes , 2014, BioMed research international.

[7]  A. Alizadehasl,et al.  Modified Ultrafiltration During Cardiopulmonary Bypass and Postoperative Course of Pediatric Cardiac Surgery , 2014, Research in cardiovascular medicine.

[8]  A. Moritz,et al.  The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiac surgery patients , 2013, Perfusion.

[9]  P. Eghtesady,et al.  Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. , 2012, The Journal of thoracic and cardiovascular surgery.

[10]  J. Chung,et al.  Assessing the Quality of Randomized Controlled Trials Published in the Journal of Korean Medical Science from 1986 to 2011 , 2012, Journal of Korean medical science.

[11]  T. Katogi,et al.  Modified versus conventional ultrafiltration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials comparing clinical outcome parameters. , 2011, The Journal of thoracic and cardiovascular surgery.

[12]  A. Moritz,et al.  Normovolemic modified ultrafiltration is associated with better preserved platelet function and less postoperative blood loss in patients undergoing complex cardiac surgery: a randomized and controlled study. , 2011, The Journal of thoracic and cardiovascular surgery.

[13]  A. Klein,et al.  The coagulopathy of cardiopulmonary bypass , 2010, Critical reviews in clinical laboratory sciences.

[14]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[15]  G. Wells,et al.  A multicenter randomized controlled trial to assess the feasibility of testing modified ultrafiltration as a blood conservation technology in cardiac surgery. , 2010, The Journal of thoracic and cardiovascular surgery.

[16]  R. Silber,et al.  Cardiac surgery in the elderly patient. , 2009, Deutsches Arzteblatt international.

[17]  T. Kohmoto,et al.  Effects of modified ultrafiltration on coagulation as measured by the thromboelastograph. , 2008, The journal of extra-corporeal technology.

[18]  S. Ahmad,et al.  Modified ultrafiltration: role in adult cardiac surgical haemostasis. , 2007, Journal of Ayub Medical College, Abbottabad : JAMC.

[19]  Glyn Williams,et al.  Modified and conventional ultrafiltration during pediatric cardiac surgery: clinical outcomes compared. , 2006, The Journal of thoracic and cardiovascular surgery.

[20]  K. Williams,et al.  Ultrafiltration reduces blood transfusions following cardiac surgery: A meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  H. Castro-Faria-Neto,et al.  Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study , 2006, Critical care.

[22]  B. Searles Ultrafiltration techniques and CPB: what we know and what we think we know. , 2006, The journal of extra-corporeal technology.

[23]  M. Manfra,et al.  Update on pediatric perfusion practice in North America: 2005 survey. , 2005, The journal of extra-corporeal technology.

[24]  I. Al-Githmi,et al.  Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. , 2005, Chest.

[25]  Xiang Xiaoyong,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment , 2005 .

[26]  T. Maehara,et al.  Effect of modified ultrafiltration on inflammatory mediators, coagulation factors, and other proteins in blood after an extracorporeal circuit. , 2004, Artificial organs.

[27]  M. Chew Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass? , 2004, Perfusion.

[28]  M. Levi,et al.  Infection and inflammation and the coagulation system. , 2003, Cardiovascular research.

[29]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[30]  A. Mazzucco,et al.  Modified Ultrafiltration Reduces Morbidity After Adult Cardiac Operations: A Prospective, Randomized Clinical Trial , 2001, Circulation.

[31]  D. McElhinney,et al.  A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. , 2001, The Journal of thoracic and cardiovascular surgery.

[32]  R. Leyh,et al.  Influence of modified ultrafiltration on coagulation, fibrinolysis and blood loss in adult cardiac surgery. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  H. Akan,et al.  Effects of combined conventional and modified ultrafiltration in adult patients. , 2001, The Annals of thoracic surgery.

[34]  M. Onoe,et al.  Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery , 2001, Perfusion.

[35]  S. Poole,et al.  Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood , 2001, Critical care medicine.

[36]  M. Onoe,et al.  Modified Ultrafiltration May Improve Postoperative Pulmonary Function in Children with a Ventricular Septal Defect , 2001, Surgery Today.

[37]  G. Schmitz,et al.  Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery. , 2000, Thrombosis research.

[38]  K. Anstrom,et al.  Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. , 2000, Journal of the American College of Cardiology.

[39]  H. Keenan,et al.  Pulmonary function after modified venovenous ultrafiltration in infants: a prospective, randomized trial. , 2000, The Journal of thoracic and cardiovascular surgery.

[40]  S. Büket,et al.  The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting , 2000, Perfusion.

[41]  F. Maly,et al.  Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  A. Redington,et al.  Modified ultrafiltration improves global left ventricular systolic function after open-heart surgery in infants and children. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[43]  P. Chai,et al.  Modified ultrafiltration versus conventional ultrafiltration: a randomized prospective study in neonatal piglets. , 1998, The Journal of thoracic and cardiovascular surgery.

[44]  M. Davies,et al.  Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. , 1998, The Journal of thoracic and cardiovascular surgery.

[45]  S. Chu,et al.  Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. , 1996, The Annals of thoracic surgery.

[46]  W. Greeley,et al.  Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac Surgery: Effects on Hemostasis, Cytokines, and Complement Components , 1994, Anesthesiology.

[47]  J. van der Linden,et al.  Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[48]  M. Elliott,et al.  Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.